The emergence of off-brand imatinib represents a significant opportunity for patients battling chronic myeloid leukemia and other illnesses. Original brand-name imatinib, commonly known as Gleevec, carries a high https://careprost087072.educationalimpactblog.com/65229285/common-imatinib-a-affordable-option